Placebo

HIGHLIGHTS •OF PRESCRIBING INFORMATION Do not …

placebo or LINZESS 290 mcg once daily on an empty stomach for 12 weeks (Trial 6) were similar to those in Table 1. Diarrhea Diarrhea was the most commonly reported adverse reaction of the LINZESS-treated patients in the pooled IBS-C pivotal placebo-controlled trials. In these trials, 20% of LINZESS-treated

  Information, Prescribing, Prescribing information, Placebo

CLINICAL STUDY PROTOCOL - Moderna

placebo-controlled study to evaluate the efficacy, safety, and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine compared to placebo in adults 18 years of age and older who have no known history of SARS-CoV-2 infection but whose locations or circumstances put them at appreciable risk of acquiring COVID-19 and/or SARS-CoV-2 infection.

  Protocol, Placebo

Evidence Assessment: Sinopharm/BBIBP COVID-19 vaccine

Apr 02, 2021 · placebo groups) • Immunogenicity showed high seropositivity in older adults but lower GMTs (both for binding antibody and neutralizing antibody) compared to younger adults • Safety • Clinical trials (N=546): • Similarsafety profile compared to younger adults, but with lower reactogenicity in older adults

  Placebo

WARNINGS AND PRECAUTIONS ----------------

is substantial evidence from placebo-controlled maintenance trials in adults with MDD that antidepressants delay the recurrence of depression and that depression itself is a risk factor for suicidal thoughts and behaviors. Monitor all antidepressant-treated patients for any indication for clinical worsening and

  Placebo

ARRDDSSnneett A OXYGENATION GOAL: PaO 55-80 mmHg …

Title: Microsoft Word - 6mlcardsmall_2008update_final_JULY2008.doc Author: Information Systems Created Date: 7/21/2008 10:53:59 AM